- Home
- TNXP vs PPBT Comparison
TNXP vs PPBT Comparison
Compare TNXP & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- PPBT
- Stock Information
- Founded
- TNXP 2007
- PPBT 2010
- Country
- TNXP United States
- PPBT Israel
- Employees
- TNXP N/A
- PPBT N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- TNXP Health Care
- PPBT Health Care
- Exchange
- TNXP Nasdaq
- PPBT Nasdaq
- Market Cap
- TNXP 19.5M
- PPBT 6.7M
- IPO Year
- TNXP N/A
- PPBT N/A
- Fundamental
- Price
- TNXP $0.61
- PPBT $3.42
- Analyst Decision
- TNXP Strong Buy
- PPBT Strong Buy
- Analyst Count
- TNXP 2
- PPBT 2
- Target Price
- TNXP $53.50
- PPBT $126.50
- AVG Volume (30 Days)
- TNXP 202.6M
- PPBT 2.7M
- Earning Date
- TNXP 11-12-2024
- PPBT 11-15-2024
- Dividend Yield
- TNXP N/A
- PPBT N/A
- EPS Growth
- TNXP N/A
- PPBT N/A
- EPS
- TNXP N/A
- PPBT N/A
- Revenue
- TNXP $11,291,000.00
- PPBT N/A
- Revenue This Year
- TNXP $62.53
- PPBT N/A
- Revenue Next Year
- TNXP $26.17
- PPBT N/A
- P/E Ratio
- TNXP N/A
- PPBT N/A
- Revenue Growth
- TNXP 183.05
- PPBT N/A
- 52 Week Low
- TNXP $0.12
- PPBT $2.00
- 52 Week High
- TNXP $14.08
- PPBT $20.60
- Technical
- Relative Strength Index (RSI)
- TNXP 75.02
- PPBT 46.33
- Support Level
- TNXP $0.32
- PPBT $3.56
- Resistance Level
- TNXP $0.72
- PPBT $4.22
- Average True Range (ATR)
- TNXP 0.15
- PPBT 0.75
- MACD
- TNXP 0.04
- PPBT -0.11
- Stochastic Oscillator
- TNXP 39.61
- PPBT 3.14
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.